Paul Sinclair is the first Australian to lead the International Pharmacy Federation. He also retins a burning passion for pharmacy in Australia. He spoke to AJP editor Chris Brooker about …

Temporary approval granted for replacement oral fluoxetine product as shortage continues Due to the shortage of fluoxetine (brand name: Zactin Tablet), the Federal Department of Health has announced it has …

Should you consent to an order under Clause 175 of the Poisons and Therapeutic Goods Regulation? lawyer Maurice Hannan investigates  In the wake of section 150 proceedings, the Pharmacy Council …

A longstanding AJP contributor, a pioneer of oncology pharmacy and a Covid vaccination and support leader are among the crop of pharmacy figures recognised in the Australia Day honours  Dr …

More than half of early career pharmacists across the Tasman say they want out of the profession, new research has revealed  Over half of the early career pharmacists in New …

Evidence suggests “promise” of safe and effective management of UTIs by community pharmacists, but more research is needed, and a viable economic model is crucial  While the available evidence suggests …

Merger news dominates our top story list for the holiday season The ongoing developments with the Sigma/Chemist Warehouse merger held our readers interest in recent months. A look at our …

Guidelines for pharmacists dispensing opioids may need to be more specific to aid in reducing opioid-related harms, say researchers Gaps in existing guidelines may be preventing pharmacists from fulfilling their …

The pharmacy calendar is starting to come together for 2024. Here’s some upcoming events APP2024 Harm Minimisation stream attracts world-renowned speakers APP2024 delegates attending this year’s Harm Minimisation stream will …

Confirmation of changes to the scheduling of laxative and antihistamine medicines, but with some last minute changes The Advisory Committee on Medicines Scheduling (ACMS) has confirmed previous preliminary changes to …

Health Minister says he is “not aware” of issues with supply of antivirals, despite surging case numbers, while deferring to expert advice on calls for widened PBS eligibility  Speaking at …

This is our final newsletter for 2023. Here’s the dates when we’ll be back in 2024 Our final newsletters for the year will be issued today (Thursday 21st): the final …